Telectronics Guardian ATP2 ICD could get panel review this year, company says.
This article was originally published in The Gray Sheet
Executive Summary
TELECTRONICS GUARDIAN ATP2 IMPLANTABLE DEFIBRILLATOR FDA PANEL REVIEW could occur later this year, the company says. Telectronics is hoping that a premarket approval application for its second-generation implantable cardioverter defibrillator will be reviewed by FDA's Circulatory System Devices Advisory Panel at a meeting scheduled for late August. The company submitted the PMA to FDA last summer.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.